32 results
8-K
EX-10.1
ACGN
Aceragen Inc
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
, or in connection with a lawsuit for retaliation for reporting a suspected violation of the law. Pursuant to the Defend Trade Secrets Act of 2016, you … , and solely for the purpose of reporting or investigating a suspected violation of law, or (b) in a complaint or other document filed in a lawsuit
8-K
EX-10.6
ACGN
Aceragen Inc
30 Sep 22
Entry into a Material Definitive Agreement
4:15pm
at 18 U.S.C. §§ 1833(b)(1) and 1833(b)(2), related to the reporting or investigation of a suspected violation of the law, or in connection with a lawsuit … for the purpose of reporting or investigating a suspected violation of law, or (b) in a complaint or other document filed in a lawsuit or other proceeding
8-K
EX-99.2
ACGN
Aceragen Inc
2 Nov 18
Departure of Directors or Certain Officers
8:31am
under seal in a lawsuit or other proceeding. Employee understands that if Employee files a lawsuit for retaliation by the Company for reporting
424B4
pdyg1c6 98vep2pu6slp
2 May 13
Prospectus supplement with pricing info
12:00am
8-K
EX-1.1
m3x js2ob
26 Nov 18
Entry into a Material Definitive Agreement
5:25pm
8-K
EX-1.1
dtahx
5 Feb 14
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12:00am
8-K
EX-1.1
yy05khbmqqwae3lc
26 Sep 13
Idera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
12:00am
DEFA14A
5z4p7lwe3 v22zac
30 Sep 22
Additional proxy soliciting materials
4:18pm